Wednesday, December 17, 2025
ADVT 
International

In U.S., Europe, hope about future health crises

Darpan News Desk The Canadian Press, 03 Feb, 2021 06:03 PM
  • In U.S., Europe, hope about future health crises

A new poll suggests people in the United States and parts of Europe believe their countries will be better equipped to handle the next major health crisis.

The Pew Research Center poll out today finds optimism for the future among a majority of 4,000 respondents in the U.S., the United Kingdom, France and Germany.

In Europe, that optimism was strongest among those who already believe their countries have done a good job in the fight against COVID-19.

In the U.S., however, confidence in the future is high — 67 per cent — regardless of whether respondents were disappointed or satisfied by the government's handling of the pandemic.

The poll, conducted by phone in November and December, carries a margin of error of between 3.7 and 4.2 percentage points, depending on the country surveyed.

It found a growing percentage of respondents in all four countries said COVID-19 had changed their lives significantly, including 74 per cent in the U.S. and 70 per cent in the U.K.

The poll did not survey Canadians, but the country took a big step Tuesday towards equipping itself for the next viral outbreak.

The federal government is ramping up Canada's capacity to manufacture vaccines, with plans to make the Novavax shot the first of its kind to be made domestically.

The poll also asked respondents how they would feel if their respective governments were to make a safe and effective COVID-19 vaccine mandatory.

Only in the U.K. did a majority of those surveyed, 62 per cent, said they would find such a policy acceptable. In France, 75 per cent of respondents said they would be opposed to a mandatory vaccine policy.

In the U.S., 57 per cent said they opposed the idea, but a much larger gap emerged when the results were divided along partisan lines.

Only 28 per cent of those who identified as conservatives said they would support requiring vaccination, compared to 60 per cent of U.S. liberals.

More broadly, a growing majority of respondents in the U.S., the U.K. and France said their lives had changed due to COVID-19.

Only in Germany did fewer than half of those surveyed say the virus had changed their lives either "a fair amount" or "a great deal." But even there, 47 per cent described significant change, up from 39 per cent in June.

In all four countries, a higher percentage of women described a significant impact from COVID-19 — a likely reflection of research that shows women losing their jobs at a higher rate than men.

MORE International ARTICLES

Norad leaders call for 'layered defence'

Norad leaders call for 'layered defence'
Fesler and O'Shaughnessy say adversaries like Russia and China are increasingly well-positioned to exploit the "seams" that currently exist between North America's air, sea and missile defence systems and early warning networks.

Norad leaders call for 'layered defence'

Trump follows Biden to battleground Michigan

Trump follows Biden to battleground Michigan
Biden plans stiff tax penalties for companies that manufacture U.S.-bound products outside the country and a crackdown on those that use offshoring to avoid paying taxes at home.

Trump follows Biden to battleground Michigan

Biden in Michigan to talk Buy American

Biden in Michigan to talk Buy American
If elected, Biden said, he would impose stiff new tax penalties on companies that manufacture U.S.-bound products outside the country, create incentives for keeping jobs on U.S. soil and close what he called "Trump loopholes" that allow companies engaged in offshoring to avoid paying U.S. taxes.

Biden in Michigan to talk Buy American

AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject

AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject
A spokesperson for AstraZeneca, via a statement said that the company’s “standard review process triggered a pause to vaccination to allow review of safety data.”

AstraZeneca vaccine trial not going ahead due to adverse reaction in a subject

Alleged neo-Nazi back in U.S. court Jan. 12

Alleged neo-Nazi back in U.S. court Jan. 12
Prosecutors, defence lawyers and District Judge Theodore Chuang gathered today via conference call to set deadlines for the government's response to the motions and to set a hearing date.

Alleged neo-Nazi back in U.S. court Jan. 12

Still too soon to try altering human embryo DNA, panel says

Still too soon to try altering human embryo DNA, panel says
Thursday’s report comes nearly two years after a Chinese scientist shocked the world by revealing he’d helped make the first gene-edited babies using a tool called CRISPR, which enables DNA changes or “edits” that can pass to future generations.

Still too soon to try altering human embryo DNA, panel says